Advertisement

Search Results for "Neuroendocrine Carcinoma Survival"

02:46 EDT 21st May 2013 | BioPortfolio

Original Source: Behaviour and survival of high-grade neuroendocrine carcinomas of the lung.

INTRODUCTION: Large-cell neuroendocrine carcinoma is an aggressive variant of large-cell carcinoma of the lung, which has poor survival in most series, resembling that of small-cell lung carcinoma. We report our retrospective assessment of surgically-resected cases of both tumours. METHODS: 33 large-cell neuroendocrine carcinomas and 16 peripheral small-cell lung carcinomas were reassessed retrospectively. Survival rates of both tumours in surgically-resected cases were calculated and compared using Kaplan-...

Matching Channels

Lung Carcinoma

Hepatocellular Carcinoma

Fibrolamellar carcinoma

Squamous Cell Carcinoma

Squamous cell carcinoma (SCC) is a carcinomatous cancer occurring in many different organs, including the skin, lips, mouth, esophagus, urinary bladder, prostate, lungs, vagina, and cervix. It is a...

Renal Cell Carcinoma

Matching News

Global neuroendocrine carcinoma market to reach $475 million by 2019; report

The global Neuroendocrine carcinoma therapeutics market was worth $127 million in 2011 and now the market is forecast to increase at compound annual growth rate (CAGR) of 17.9% to reach $475 million b...

Chemotherapy effective for patients with resected SCLC or large-cell neuroendocrine carcinoma

(International Association for the Study of Lung Cancer) Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology,...

For Patients With Resected SCLC Or Large-Cell Neuroendocrine Carcinoma, Chemotherapy Found To Be Effective

Research presented in the July 2012 issue of the International Association for the Study of Lung Cancer's (IASLC) Journal of Thoracic Oncology, concluded that patients with limited large cell neuroend...

[Articles] Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study

Conditional survival is a clinically useful prediction measure that adjusts prognosis of patients with metastatic renal-cell carcinoma on the basis of survival since treatment initiation or therapy du...

Prognostic factors identified in mucoepidermoid carcinoma

(HealthDay) -- Diagnosis of low- or intermediate-grade tumors is associated with significantly better overall survival and disease-free survival in patients with mucoepidermoid carcinoma (MEC) of the...

Common therapies for basal cell carcinoma offer similar survival

(HealthDay) -- For patients with superficial basal cell carcinoma (sBCC), treatment with imiquimod or photodynamic therapy (PDT) results in similar long-term tumor-free survival, according to a review...

Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients

Peptide receptor radionuclide therapy with 90Y-DOTATATE/90Y-DOTATOC in patients with progressive metastatic neuroendocrine tumours: assessment of response, survival and toxicity

Matching PubMed Articles

Behaviour and survival of high-grade neuroendocrine carcinomas of the lung.

INTRODUCTION: Large-cell neuroendocrine carcinoma is an aggressive variant of large-cell carcinoma of the lung, which has poor survival in most series, resembling that of small-cell lung carcinoma. We...

Bilateral primary breast neuroendocrine carcinoma in a young woman: Report of a case.

Bilateral breast carcinoma accounts for approximately 5% of all patients with breast cancer, while neuroendocrine breast carcinomas comprise less than 5% of invasive breast carcinomas. In addition, mo...

Fast-growing large cell neuroendocrine carcinoma of mediastinum.

Neuroendocrine carcinomas combine a heterogeneous group of tumors occurring in lungs on a rare occasion, and in some cases, they appear to have extraordinary quick growth and extrapulmonary localizati...

Distribution, Incidence, and Prognosis in Neuroendocrine Tumors: a Population Based Study from a Cancer Registry.

Neuroendocrine tumors are considered rare tumors: recently an increased incidence and an improvement in survival were described. We explore distribution, incidence and survival of neuroendocrine tumor...

Increased neuroendocrine cells in resected metastases compared to primary colorectal adenocarcinomas.

Neuroendocrine differentiation has been described in rectal adenocarcinomas receiving neoadjuvant therapy prior to radical surgery, but its clinical relevance is controversial and no data are currentl...

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement